课题基金 / 基金详情

Germline mutations in mismatch repair genes: prevalence, risk of cancer, and environmental modifiers of risk.

Germline mutations in mismatch repair genes: prevalence, risk of cancer, and environmental modifiers of risk.
错配修复基因的种系突变:患病率、癌症风险和风险的环境调节因素。
批准号:
nhmrc : 400160
负责人:
Dr Laura Baglietto
金额:
$14.45万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2006
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2006-01-01 至 2008-12-31

项目摘要

项目成果

Dr Laura Baglietto的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Aims: 1. Develop a model that will predict who has a mutation in a group of genes that cause cancer 2. Estimate risk of cancer in people who have a mutation in these genes (carriers) 3. Determine if cancer risk in carriers can be reduced People who inherit a mutation in a group of genes called 'mismatch repair genes' are at increased risk of cancer, particularly cancer of the colon and rectum. If these carriers can be identified they can take preventive measures such as screening to reduce their risk of cancer and death. We will develop a model using data from the Colon Cancer Family Registry (CFR), the world's largest dataset of carriers and non-carriers which has already recruited and genetically tested over 4,000 families from Australasia, USA and Canada. The model will allow clinicians to predict who is a likely be a carrier based so they can be tested for the mutation. We know the risk of cancer is high in carriers, but we don't have precise estimates. We will use the Colon CFR applying sophisticated statistical methods required to answer this question. This data is critical for genetic counselling so appropriate decisions can be made by the patient and the doctor as to what preventive measures to take. We will also use the Colon CFR data to find out what how the carriers who develop cancer differ from those who stay cancer free using their completed lifestyle questionnaires which includes questions on diet, smoking, alcohol consumption, exercise, aspirin use, and oral contraceptive pill use. We may identify risk factors that carriers can avoid (or take up if they reduce cancer risk) to reduce their risk of cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Risk of recurrence after diagnosis of invasive breast cancer by molecular subtype as defined by ER, PR and her2 status
  • 批准号:
    nhmrc : 1029903
  • 项目类别:
    Project Grants
  • 资助金额:
    $33.38万
  • 财政年份:
    2012
  • 负责人:
    Dr Laura Baglietto
  • 依托单位:
Methylation as a risk and prognostic factor for breast cancer
  • 批准号:
    nhmrc : 1011618
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $39.67万
  • 财政年份:
    2011
  • 负责人:
    Dr Laura Baglietto
  • 依托单位:
Vitamin D and risk of cancer and mortality in the Melbourne Collaborative Cohort Study
  • 批准号:
    nhmrc : 623208
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $34.66万
  • 财政年份:
    2010
  • 负责人:
    Dr Laura Baglietto
  • 依托单位:
国内基金
海外基金
DelineatingthemolecularmechanismsunderlyingmammaryepithelialcellcarcinogenesisinpatientswithinheritedBRCA1andBRCA2mutations
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    160万元
  • 批准年份:
    2022
  • 负责人:
    TAKEDA SHUNICHI
  • 依托单位:
丙型肝炎病毒感染宿主细胞的分子生物学研究